Evidence map›Paper›PMID 37664796›Full record

ArticleMaterials today. Bio2023

Silane-modified hydroxyapatite nanoparticles incorporated into polydioxanone/poly(lactide-

Behzad Shiroud Heidari, Emma Muinos Lopez, Peilin Chen, Rui Ruan, Ebrahim Vahabli, Seyed Mohammad Davachi, Froilán Granero-Moltó, Elena M De-Juan-Pardo, Minghao Zheng, Barry Doyle

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Behzad Shiroud HeidariHarry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands and the UWA Centre for Medical Research, The University of Western Australia, Perth, Australia.
Emma Muinos LopezCell Therapy Area, Centro de Investigación Médica Aplicada, IDISNA, Universidad de Navarra, Pamplona, Spain.
Peilin ChenCentre for Orthopaedic Research, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Australia.
Rui RuanCentre for Orthopaedic Research, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Australia.
Ebrahim VahabliHarry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands and the UWA Centre for Medical Research, The University of Western Australia, Perth, Australia.
Seyed Mohammad DavachiDepartment of Biology and Chemistry, Texas A&M International University, Laredo, TX, USA.
Froilán Granero-MoltóCell Therapy Area, Centro de Investigación Médica Aplicada, IDISNA, Universidad de Navarra, Pamplona, Spain.
Elena M De-Juan-PardoHarry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands and the UWA Centre for Medical Research, The University of Western Australia, Perth, Australia.
Minghao ZhengCentre for Orthopaedic Research, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Australia.
Barry DoyleHarry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands and the UWA Centre for Medical Research, The University of Western Australia, Perth, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interface tissue between bone and soft tissues, such as tendon and ligament (TL), is highly prone to injury. Although different biomaterials have been developed for TL regeneration, few address the challenges of the TL-bone interface. Here, we aim to develop novel hybrid nanocomposites based on poly(

Indexed as

HydroxyapatiteInterface tissueNanocompositesSilane modificationTendon enthesis

Identifiers

PMID37664796
PMCPMC10474235

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.